Human papillomavirus (HPV) insertional mutation as a dynamic & specific tumour biomarker in HPV-associated carcinoma.

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16

Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med (2009) 5.79

Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology (1989) 1.46

Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol (2004) 1.41

Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer (2014) 1.40

MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene (2006) 1.31

Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease. J Virol (2014) 1.26

APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO J (1998) 1.02

Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis. BMC Cancer (2014) 0.95

Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients. PLoS One (2012) 0.89

Human papillomavirus (HPV) genome status & cervical cancer outcome - A retrospective study. Indian J Med Res (2015) 0.81